"Old School" Islet Purification Based on the Unit Gravity Sedimentation as a Rescue Technique for Intraportal Islet Transplantation-A Case Report.


Journal

Cell transplantation
ISSN: 1555-3892
Titre abrégé: Cell Transplant
Pays: United States
ID NLM: 9208854

Informations de publication

Date de publication:
Historique:
entrez: 5 8 2020
pubmed: 5 8 2020
medline: 20 7 2021
Statut: ppublish

Résumé

Here, we present a case that required a supplemental "old school" islet purification for a safe intraportal infusion. Following pancreas procurement from a brain-dead 26-year-old male donor (body mass index: 21.9), 24.6 ml of islet tissue was isolated after continuous density gradient centrifugation. The islet yield was 504,000 islet equivalent (IEQ), distributed among the following three fractions: 64,161 IEQ in 0.6 ml of pellet, 182,058 IEQ in 10 ml, and 258,010 IEQ in 14 ml with 95%, 20%, and 10% purity, respectively. After a 23-h culture, we applied supplemental islet purification, based on the separation of tissue subfractions during unit gravity sedimentation, a technique developed over 60 years ago ("old school"). This method enabled the reduction of the total pellet volume to 11.6 ml, while retaining 374,940 IEQ with a viability of over 90%. The final islet product was prepared in three infusion bags, containing 130,926 IEQ in 2.6 ml of pellet, 108,079 IEQ in 4 ml of pellet, and 135,935 IEQ in 5 ml of pellet with 65%, 40%, and 30% purity, respectively, and with the addition of unfractionated heparin (70 units/kg body weight). Upon the islet infusion from all three bags, portal pressure increased from 7 to 16 mmHg. Antithrombotic prophylaxis with heparin was continued for 48 h after the infusion, with target activated partial thromboplastin time 50-60 s, followed by fractionated heparin subcutaneous injections for 2 weeks. β-Cell graft function assessed on day 75 post-transplantation was good, according to Igls criteria, with complete elimination of severe hypoglycemic episodes and 50% reduction in insulin requirements. Time spent within the target glucose range (70-180 mg/dl) improved from 42% to 98% and HbA1c declined from 8.7% to 6.7%. Supplemental "old school" islet purification allowed for the safe and successful utilization of a robust and high-quality islet preparation, which otherwise would have been discarded.

Identifiants

pubmed: 32749147
doi: 10.1177/0963689720947098
pmc: PMC7563026
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

963689720947098

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK020595
Pays : United States

Références

Transplantation. 2011 Dec 15;92(11):1222-30
pubmed: 22089666
CellR4 Repair Replace Regen Reprogram. 2014;2(2):
pubmed: 30581890
Transplantation. 2000 Mar 15;69(5):756-61
pubmed: 10755522
Transplant Proc. 2004 Nov;36(9):2849-54
pubmed: 15621166
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613695
J Mol Med (Berl). 1999 Jan;77(1):45-8
pubmed: 9930926
Biochem Biophys Res Commun. 1977 Dec 7;79(3):823-8
pubmed: 202276
J Surg Res. 1988 Nov;45(5):432-42
pubmed: 3141720
CellR4 Repair Replace Regen Reprogram. 2015;3(1):
pubmed: 30613705
Transplant Proc. 2011 Nov;43(9):3181-3
pubmed: 22099751
Diabetes. 2004 Jun;53(6):1407-11
pubmed: 15161741
Transpl Int. 2018 Apr;31(4):343-352
pubmed: 29453879
Diabetes. 2016 Nov;65(11):3418-3428
pubmed: 27465220
Am J Transplant. 2018 Apr;18(4):945-951
pubmed: 28941330
Transplantation. 1991 Sep;52(3):450-2
pubmed: 1716795
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613690
Transplantation. 2009 Jun 15;87(11):1629-35
pubmed: 19502953
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30720967
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613694
Am J Transplant. 2019 Mar;19(3):831-843
pubmed: 30203908
PLoS One. 2019 Jul 19;14(7):e0220064
pubmed: 31323061
Transplant Proc. 2010 Jul-Aug;42(6):2024-6
pubmed: 20692398
Ups J Med Sci. 2000;105(2):125-33
pubmed: 11095109
Diabetologia. 2006 Aug;49(8):1845-54
pubmed: 16783471
Transplantation. 1993 Mar;55(3):661-3
pubmed: 8456488
J Clin Endocrinol Metab. 2015 Jun;100(6):2314-21
pubmed: 25816051
Cell Transplant. 2019 Feb;28(2):185-194
pubmed: 30520321
Cell Transplant. 2016;25(8):1515-1523
pubmed: 26922947
CellR4 Repair Replace Regen Reprogram. 2014;2(3):
pubmed: 30613688
Transplantation. 2002 Oct 15;74(7):913-5
pubmed: 12394830
Front Med (Lausanne). 2018 Jul 13;5:202
pubmed: 30057900
Diabetologia. 2009 Mar;52(3):477-85
pubmed: 19130038
Transplant Proc. 1992 Dec;24(6):2796-7
pubmed: 1465944
Transpl Int. 2003 Sep;16(9):613-32
pubmed: 12928769
Biotechnol Genet Eng Rev. 2012;28:101-14
pubmed: 22616483
Cytotechnology. 2015 Mar;67(2):199-206
pubmed: 24443076
Am J Transplant. 2005 Jan;5(1):21-30
pubmed: 15636608
Transplant Proc. 2011 Nov;43(9):3161-6
pubmed: 22099746
Cell Transplant. 2009;18(1):13-22
pubmed: 19476205
Diabetes. 2001 Nov;50(11):2464-71
pubmed: 11679423
Adv Exp Med Biol. 2016;938:1-9
pubmed: 27586418

Auteurs

Justyna E Gołębiewska (JE)

Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.
Both the authors contributed equally to this article.

Karolina Gołąb (K)

Transplantation Institute, University of Chicago, Chicago, IL, USA.
Both the authors contributed equally to this article.

Tomasz Gorycki (T)

Department of Radiology, Medical University of Gdańsk, Gdańsk, Poland.

Maciej Śledziński (M)

Department of General, Endocrine and Transplant Surgery, Medical University of Gdańsk, Gdańsk, Poland.

Jacek Gulczyński (J)

Laboratory for Cell and Tissue Banking and Transplantation- CellT, Gdańsk, Poland.
Department of Pathology and Neuropathology, Medical University of Gdańsk, Gdańsk, Poland.

Iwona Żygowska (I)

Laboratory for Cell and Tissue Banking and Transplantation- CellT, Gdańsk, Poland.

Bogumił Wolnik (B)

Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland.

Michał Hoffmann (M)

Diabetes Research Institute and Cell Transplantation Center, University of Miami, Miami, FL, USA.

Piotr Witkowski (P)

Transplantation Institute, University of Chicago, Chicago, IL, USA.

Camillo Ricordi (C)

Diabetes Research Institute and Cell Transplantation Center, University of Miami, Miami, FL, USA.

Edyta Szurowska (E)

Department of Radiology, Medical University of Gdańsk, Gdańsk, Poland.

Zbigniew Śledziński (Z)

Department of General, Endocrine and Transplant Surgery, Medical University of Gdańsk, Gdańsk, Poland.

Alicja Dębska-Ślizień (A)

Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH